Понедельник, 28.09.2020, 05:47
The Alchevsk Post
Главная Регистрация Вход
Приветствую Вас, Гость · RSS
Меню сайта
реклама
Реклама
Газовые котлы в Днепре
Статистика

Онлайн всего: 1
Гостей: 1
Пользователей: 0
Форма входа
 Доска объявлений Алчевск
Главная » Доска объявлений » Услуги в разных сферах » Медицинские услуги, здоровье [ Добавить объявление ]

Dr. Misha V. Blagosklonny
Предложение | 30.09.2019, 20:36

Misha V. Blagosklonny graduated with an MD and PhD from First Pavlov State Medical
University of St. Petersburg, RUS. Dr. Misha V. Blagosklonny subsequently
Moved to the United States, where he received the prestigious Fogarty Fellowship from the National Institutes of Health.
Within the period of his fellowship in Leonard Neckers’ laboratory at the National
Cancer Institute (NCI), he was a co-author of 18 publications on
Diverse biomedical themes, including targeting
HSP90, p53, Bcl2, Erb2, and Raf-1. He also was the last author on a clinical phase I/II
Trial publication.
 
After authoring seven papers during a brief yet resulting
Senior research fellowship in the El-Deiry Cancer Research Lab at the University of Pennsylvania,
Dr. Blagosklonny returned to NCI to team up with Tito Fojo. Together, they
Published 26 papers. In addition, Dr. Mikhail Blagosklonny published many of experimental research papers and theoretical articles as sole
Writer. The abovementioned sole-author publications
Encompassed two important themes.
The first of those explained selectively killing cancer
Cells with deregulated cell cycle or drug resistance by
Exploiting their resistance. The results and underlying
Concept were so revolutionary that they were incorrectly cited by
Other scientists as “reversal of resistance, ” even though the work was
Titled, “Exploiting of drug resistance instead of its reversal. ” One great
Supporter of this concept was the world-famous scientist Arthur Pardee, with whom Dr.
Blagosklonny co-authored a joint article in 2001.
 
The second topic throughout Dr. Blagosklonny’s sole-author articles
Is a research method to come up with knowledge via
Bringing a few facts together from seemingly irrelevant fields.
This results in new notions containing testable predictions, which in
Turn can be “tested” by analyzing the literature further. Likewise, the
Concept was co-authored by Arthur Pardee in a 2002 article in Nature. The
First success of the new research method was the description of the feedback
Regulation of p53, as supported by the discovery of mdm2/p53 loop; and the
Explanation why mutant p53 is always overexpressed, published in 1997. The most
Noticeable result discovered by Dr.
Blagosklonny’s research methods is the hyperfunction (or quasi-programmed)
Theory of aging and the revelation of rapamycin as an exceptionally well-tolerated
Anti-aging drug, published in 2006. As mentioned in Scientific American,
Michael Hall, who discovered mTOR in 1991, gives Dr. Blagosklonny credit for
“connecting dots that others can’t even see. ”
 
In 2002, Dr. Blagosklonny became associate professor of medicine at New York Medical College.
He agreed to accept responsibilities as a senior scientist at Ordway
Research Institute in Albany, New York, in 2005, before receiving another
Position at Roswell Park Cancer Institute as professor of oncology in 2009.
 
Since joining Roswell Park Comprehensive Cancer Center in 2009, Dr. Blagosklonny
Has studied the prevention of cancer (an age-related disease) via
Inhibiting organism aging — in other words, “preventing cancer
By staying young. ” His lab closely worked together with
Andrei Gudkov’s and finalized research on the suppression of
Cellular senescence, namely suppression of cellular conversion from healthy quiescence to
Permanent senescence. This resulted in the discovery of additional anti-aging
Drugs besides rapamycin. The cell culture studies were
Accompanied by studies in mice, including a few models like
Standard and aging mice, p53-deficient mice, and mice on a high-fat diet.
 
Dr. Mikhail Blagosklonny has also published extensively on the stoppage of cellular
Senescence by rapamycin and other mTOR inhibitors, life
Prolongation and cancer stoppage in mice, and combinations of anti-
Aging medications to be used in humans. A
Rapamycin-based combination of seven clinically available medications has
Been named the “Koschei Formula” and is now utilized for the treatment of aging in patients
At the Alan Green Clinic in Little Neck, New York.

https://www.crunchbase.com/person/mikhail-blagosklonny#section-overview
https://www.tandfonline.com/doi/pdf/10.4161/cbt.8.9.8899
https://www.ru-scitech-forum.org/wp-content/uploads/AndreiGudkov.pdf

 

Добавил: greenvikzal |
Просмотров: 65 | Рейтинг: 0.0/0
Всего комментариев: 0
Добавлять комментарии могут только зарегистрированные пользователи.
[ Регистрация | Вход ]
Copyright MyCorp © 2020
Поиск
Бесплатный конструктор сайтов - uCoz